Senior Director, Global Regulatory Affairs Liaison – Pediatric Center of Excellence at Gilead Sciences

Dublin, County Dublin, Ireland

Gilead Sciences Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Act as Franchise Lead for Regulatory Affairs at the Pediatric Center of Excellence
  • Provide leadership and mentorship for direct reports
  • Oversee and guide development and execution of regulatory strategies, plans, and objectives for pediatric development across Virology, Oncology, and Inflammation therapeutic areas, aligned with global product development
  • Oversee development of global pediatric regulatory plans and preparation of pediatric regulatory submissions
  • Monitor progress and completion of global pediatric commitments
  • Guide and advise colleagues in thorough and compliant completion of regulatory activities
  • Act as Global Regulatory Lead and/or Gilead contact to/for regulatory authorities as needed
  • Serve as senior regulatory representative and pediatric subject matter expert to cross-functional leaders and teams
  • Play leadership role on regulatory leadership teams at the Pediatric Center of Excellence
  • Participate in ad hoc or special projects/initiatives to improve or advance GRA capabilities

Responsibilities

  • Accountable for oversight and leadership of the development and successful completion of global pediatric regulatory strategies, submissions, documents, activities, and other deliverables for products across Virology, Oncology, and Inflammation therapeutic areas to achieve strategic milestones and objectives
  • Make significant contributions to the ongoing development and optimization of pediatric regulatory strategies, processes, standards, and practices in collaboration across Global TA regulatory liaisons

Skills

Regulatory Affairs
Global Regulatory Strategy
Therapeutic Area Liaison
Drug Development
Regulatory Agency Interactions
Licensure Management
Regulatory Filings
Cross-functional Collaboration
Pediatric Regulations

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI